HEAL Commercialization Readiness Pilot (CRP) Program: Embedded Entrepreneurs for Small Businesses in Pain Management (SB1 Clinical Trial Not Allowed)

US Dept. of Health & Human Services: National Institutes of Health (NIH)

Next deadline: Apr 5, 2023 (Full proposal)

Later deadlines: Aug 5, 2023 (Letter of inquiry), Sep 5, 2023 (Full proposal), Mar 5, 2024 (Letter of inquiry), Apr 5, 2024 (Full proposal), Aug 5, 2024 (Letter of inquiry), Sep 5, 2024 (Full proposal), Mar 5, 2025 (Letter of inquiry), Apr 5, 2025 (Full proposal), Aug 5, 2025 (Letter of inquiry), Sep 5, 2025 (Full proposal)

Grant amount: Up to US $400,000

Funding uses: Research, Project / Program, Training / Capacity Building

Location of project: United States

Location of residency: United States

Overview:

NOTE: All applications are due by 5:00 PM local time of applicant organization. 

The purpose of this Funding Opportunity Announcement (FOA) is to facilitate the transition of previously funded SBIR and STTR Phase II and Phase IIB projects in pain management to the commercialization stage by providing additional assistance for private partnering activities through the Commercialization Readiness Pilot (CRP) program. Specifically, this FOA supports the addition of entrepreneurial expertise into small business leadership teams along with supporting partnering activities to aid in commercialization through private third-party funding or partnership with industry.

We've imported the main document for this grant to give you an overview. You can learn more about this opportunity by visiting the funder's website.